46 related articles for article (PubMed ID: 1597847)
1. Effects of nicardipine on the metabolic responses to food and exercise.
Ahmed JH; Elliott HL; Hosie J; Farish E; Reid JL
J Hum Hypertens; 1992 Apr; 6(2):139-44. PubMed ID: 1597847
[TBL] [Abstract][Full Text] [Related]
2. Dose requirement and effect of nicardipine on lipid profile in mild to moderate essential hypertensives.
Tariq AR; Maheendran K; Kamsiah J; Christina P
Med J Malaysia; 1992 Sep; 47(3):182-9. PubMed ID: 1491643
[TBL] [Abstract][Full Text] [Related]
3. Twice-daily nicardipine in the treatment of essential hypertension.
Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
[TBL] [Abstract][Full Text] [Related]
4. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study.
Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538
[TBL] [Abstract][Full Text] [Related]
5. Diltiazem vs. nicardipine on ambulatory and exercise blood pressure and on peripheral hemodynamics.
Palatini P; Casiglia E; Graniero GR; Dorigatti F; Lotoro F; Vriz O; Pessina AC
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):38-42. PubMed ID: 7711991
[TBL] [Abstract][Full Text] [Related]
6. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and tolerance of LA 50 mg nicardipine in hypertensive athletes].
Marcadet DM; Blanc AS; Lopez AA; Preziosi JP; Guignard MM; Baggio S; Sassano P
Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1569-74. PubMed ID: 1763923
[TBL] [Abstract][Full Text] [Related]
8. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Bouvier JM; Rabot D; Herrero G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation.
Kovac AL; Masiongale A
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):45-50. PubMed ID: 17289479
[TBL] [Abstract][Full Text] [Related]
10. The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.
Jones RI; Hornung RS; Sonecha T; Raftery EB
J Hypertens; 1983 Jun; 1(1):85-9. PubMed ID: 6681029
[TBL] [Abstract][Full Text] [Related]
11. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
[TBL] [Abstract][Full Text] [Related]
12. Nitrendipine once daily compared with nicardipine in the treatment of mild to moderate hypertension.
Palermo R; Conti V; Agostinelli MC; Ganzetti S; Racco F; Melappioni A; Pratillo G; Moretti S
Clin Ther; 1990; 12(2):149-56. PubMed ID: 2354484
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
Di Pasquale G; Lusa AM; Manini GL; Dominici P; Coluccini M; Bassein L; Pinelli G
G Ital Cardiol; 1984 Aug; 14(8):618-20. PubMed ID: 6500225
[TBL] [Abstract][Full Text] [Related]
14. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
Meywald W; Maass L; Verho M; Rangoonwala B
Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
[TBL] [Abstract][Full Text] [Related]
15. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive action of nicardipine retard in 24 hours and its effect on stress].
De Cesaris R; Ranieri G; Andriani A; Filitti V; Bonfantino MV; Lamontanara G; Ferrieri A
Minerva Med; 1993 Oct; 84(10):533-9. PubMed ID: 8247308
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy and safety of slow-release nicardipine vs nifedipine in angina].
Villanova C; Maddalena F; Rocco CG
Minerva Cardioangiol; 1994 Dec; 42(12):583-9. PubMed ID: 7753427
[TBL] [Abstract][Full Text] [Related]
19. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
20. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
